[Safety and efficacy of the early administration of levosimendan in patients with acute non-ST-segment elevation myocardial infarction and elevated NT-proBNP levels: An Early Management Strategy of Acute Heart Failure (EMS-AHF)].
Xu F, Bian Y, Zhang GQ, Gao LY, Liu YF, Liu TX, Li G, Song RX, Su LJ, Zhou YJ, Cui JY, Yan XL, Guo FM, Zhang HY, Li QH, Zhao M, Ma LK, You BA, Wang G, Kong L, Ma JL, Zhou XF, Chang ZL, Tang ZY, Yu DY, Cheng K, Xue L, Li X, Pang JJ, Wang JL, Zhang HT, Yu XZ, Chen YG.
Xu F, et al. Among authors: chang zl.
Zhonghua Nei Ke Za Zhi. 2023 Apr 1;62(4):374-383. doi: 10.3760/cma.j.cn112138-20220420-00284.
Zhonghua Nei Ke Za Zhi. 2023.
PMID: 37032132
Clinical Trial.
Chinese.